| Product Type | Impurity Standards |
| CAT. No. | MRL-A116001 |
| CAS. No. | 68475-42-3 |
| Mol. Formula | C10H7Cl2N3O |
| Mol. Weight | 256.09 |
| Synonyms | Xagrid |
| Chemical Name | 6,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one (as per USP) |
| HSN Code | 38229010 |
| Country of Origin | India |
| Stock Status | Custom Synthesis |
Anagrelide, a quinazolinone derivative, inhibits phosphodiesterase activity, particularly phosphodiesterase-III, leading to decreased platelet production in the bone marrow. Its chemical structure, with a quinazolinone core and chlorine substitutions, is crucial for its pharmacological activity. Anagrelide is employed in the treatment of essential thrombocythemia, a condition characterized by elevated platelet levels, by selectively reducing platelet production. Administered orally, it is often considered when other treatments are not well-tolerated, providing a targeted approach to managing platelet counts and mitigating the risk of thrombotic events in affected individuals. Buy high quality Anagrelide from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of Anagrelide